Search for Clinical Trials
IKT-148009-201/ A Phase 2, randomized, double-blind, placebo-controlled trial of IKT-148009 in untreated Parkinson's diseaseThe purpose of this study…
A 17-Week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, multicenter study of the efficacy and safety of…
An open-label study of the long-term safety and tolerability of Sage-324 in participants with essential tremorThe purpose of this study is to…
Sage Therapeutics, Inc. is sponsoring this study of an investigational drug called SAGE-718. SAGE-718 is being evaluated for possible…
This is a research study being conducted by Dr. Chi-Ying (Roy) Lin through the Baylor College of Medicine, under the funding of CurePSP.Being in this…
An extension of studies to evaluate Abbv-951 in subjects with advanced Parkinson's disease (H-52937)
Abbvie Inc. - An Open-label extension of studies M15-736 and M20-339 to evaluate the safety and tolerability of 24-hour daily exposure of Abbv-951 in…
The Relight clinical research study is currently testing an investigational medication for people living with depression, or Major Depressive…
Multiple gestation increases the risk of preterm delivery. Babies born preterm have increased rates of neonatal mortality and long-term…
Emerging data support a link between sleep disordered breathing (SDB) and adverse pregnancy outcomes. In particular, women with obstructive sleep…
The goal is to determine whether treatment of mild chronic hypertension in pregnancy influences maternal risk of cardiovascular disease (CVD) and to…
